Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor
The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
The estrogen receptor (ER) is a key regulator of proliferation and differentiation in breast cancer cells. In the present study, the effect of steroid and xenobiotic receptor (SXR) on 17/beta-estradiol (E2)-induced transcription through ERalpha was studied. SXR augmented ER-mediated transcription in the presence of E2 in MCF-7 breast cancer-derived cells and CV-1 fibroblast-derived cells. On the other hand, SXR alone did not affect the estrogen response element (ERE)-containing promoter activity in CV-1 cells. SXR did not directly bind to ERalpha or ERE in vitro, indicating that SXR may affect ER-mediated transcription by altering cofactor binding to ER. Although SXR did not alter the binding between ERalpha and p300/CBP interacting protein (p/CIP), it decreased the binding of a specific corepressor, silencing mediator of retinoid and thyroid hormone receptors (SMRT) to liganded ERalpha as assessed by mammalian two-hybrid, glutathione S-transferase pull-down, immunoprecipitation and newly developed Liquid Chemiluminescent DNA Pull-Down Assays. These results indicate that SXR augmented ER-mediated transcription by dissociating SMRT from ERalpha. Thus, the expression of SXR in breast cancer cells may alter the ER signaling, which may play crucial role for growth and differentiation of breast cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, some of them may activate the phosphorylation of proteins [151, 152].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [152]
In the citing paper
“Many endocrine disruptors may affect the transcriptional activity of nuclear receptors by changing the action of competitively binding with ligand biding domain, which may modify coactivator activity and dissociate corepressors that reduce deacetylases action.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [152]
In the citing paper
“Some endocrine disruptors may also modify DNA methylation in the regulatory region of specific genes.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [152]
Citations
Cites
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034 · cited 1×
“Among corepressors, nuclear receptor corepressor (N-CoR) [ 30 ] and silencing mediator of retinoid and thyroid hormone receptors (SMRT) [31] have been implicated in mediating ER signaling.”
BackgroundDifferential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657 · cited 1×
“Tamoxifen (TAM) induced the activity (column 5), indicating that the binding between ERa and SMRT may be increased, as previously reported [40–43].”
ResultLehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576 · cited 1×
“On the other hand, steroid and xenobiotic receptor (SXR) is highly expressed in the liver and small intestine and regulates the expression of cytochrome P450 monooxygenase 3A4 (CYP3A4) and P-glycoprotein (P-gp) that is encoded by multidrug resistance 1 (MDR1) gene [6–12].”
BackgroundAn Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146 · cited 2×
“Since pCIP/TRAM-1/SRC-3 is highly expressed in MCF-7 cells [42], we used p/CIP constructs in our mammalian two-hybrid studies.”
MethodResultSXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Willson, T. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001215200 · Cited by 815 · cited 2×
“Although interaction of N-CoR and/or SMRT with SXR in hepatocytederived cells has been reported [37, 38 ], the interaction of SXR and these corepressors, and their possible involvement on progression of breast cancer have not been clarified.”
Method
Research works printed but not linked: 1
- R.N. Cohen, A. Putney, F.E. Wondisford, A.N. Hollenberg, The nuclear hormone receptors recognize distinct nuclear receptor complex. Mol. Endocrinol. 14, 900–914 (2000) · doi:10.1210/mend.14.6.0474 · Paper page
Cited by
Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines
Gasnier, C., Dumont, C., Benachour, N., Clair, E., Chagnon, M.-C., & Séralini, G.-E. (2009) · Toxicology · doi:10.1016/j.tox.2009.06.006 · Cited by 658
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
“Furthermore, some of themmay activate the phosphorylation of proteins [151, 152].”
BackgroundSansone, A., Romanelli, F., Sansone, M., Lenzi, A., & Luigi, L. D. (2016) · Endocrine · doi:10.1007/s12020-016-0975-9 · Cited by 140
Biswas, A., Mani, S., Redinbo, M. R., Krasowski, M. D., Li, H., & Ekins, S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9901-7 · Cited by 64
“However, other reports show that PXR can induce cell proliferation in breast cancer through mechanisms involving the organic anion transporter 1A2 (OATP1A2) mediated import of estrogen sulphate and/or by altering co-repressor (SMRT) binding to estrogen receptor-α (ERα) (74).”
BackgroundSteroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer
Yue, X., Akahira, J., Utsunomiya, H., Miki, Y., Takahashi, N., Niikura, H., Ito, K., Sasano, H., Okamura, K., & Yaegashi, N. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02546.x · Cited by 22
Metadata
- Authors
- Rokutanda, N., Iwasaki, T., Odawara, H., Nagaoka, R., Miyazaki, W., Takeshita, A., Koibuchi, Y., Horiguchi, J., Shimokawa, N., Iino, Y., Morishita, Y., & Koibuchi, N.
- Affiliations
- Gunma University (JP)
- Toranomon Hospital (JP)
- Corresponding author
- Iwasaki, Toshiharu
- Venue
- Endocrine
- Published
- 2008-06
- Volume
- 33
- Issue
- 3
- Pages
- 305-316
- ISSN
- 0969-711X (ISSN-L)
- 1355-008X
- 1559-0100
- OpenAlex
- W2021615649
- Cited by
- 11
- References
- 57
- Citations by year
- 2026: 1 · 2021: 1 · 2019: 1 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- estrogen receptor alpha, pregnane X receptor, estradiol, transcriptional coactivation, SMRT corepressor, estrogen response element, breast cancer, MCF-7 cells, transcriptional cofactors
- MeSH terms
- Pregnane X Receptor, Base Sequence, Breast Neoplasms, Cell Differentiation, Cell Division, DNA-Binding Proteins, Dose-Response Relationship, Drug, Estradiol, Humans, Promoter Regions, Genetic, Receptors, Steroid, Repressor Proteins, Transcription, Genetic, Signal Transduction, Gene Expression Regulation, Neoplastic, ATP Binding Cassette Transporter, Subfamily B, Member 1, Cell Line, Tumor, Estrogen Receptor alpha, Nuclear Receptor Co-Repressor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor. https://app.cochat.ai/papers/10.1007/s12020-008-9091-9
- The paper
- Rokutanda, N., Iwasaki, T., Odawara, H., Nagaoka, R., Miyazaki, W., Takeshita, A., Koibuchi, Y., Horiguchi, J., Shimokawa, N., Iino, Y., Morishita, Y., & Koibuchi, N. (2008). Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor. Endocrine. https://doi.org/10.1007/s12020-008-9091-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.